Haisco Pharmaceutical Group Co., Ltd. (002653.SZ) SHZ
55.34
-2.51(-4.34%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
55.34
-2.51(-4.34%)
Currency In CNY
Sector
Healthcare
Industry
Biotechnology
Employees
5337
First IPO Date
January 17, 2012
| Name | Title | Pay | Year Born |
| Meng Wang | Deputy GM & Board Secretary | 0 | 1986 |
| Han Bing Liu | Human Resources Manager | 0 | 1982 |
| Peng Duan | Chief Financial Officer | 0 | 1977 |
| Xiu Lian Fan | MD, GM & Director | 0 | 1963 |
Haisco Pharmaceutical Group Co., Ltd., together with its subsidiaries, develops, produces, and sells drugs in China. The company offers small-volume injections, freeze-dried powder injections, powder injections, large-volume injections, active pharmaceutical ingredient, etc. for various therapeutic fields, including anti-infective, digestive system, blood system, nervous system, parenteral nutrition, antibiotics, first aid, anesthetics, and tumor; and tablets, capsules, granules, and ointments in the fields of cardiovascular, anti-infection, digestive system, CNS system, diabetes, and hepatic diseases. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2000 and is based in Shannan, China.